When you launch a cure that doesn't
I don’t have the answers to this one, but it is an important question… What happened?
Excuse my scribbles on this chart - note launch of a ‘cure’ for Hepatitis C in 2013/14, calculations at the time that 260k people per year would essentially rid the US of HepC, and then a peak of people initiating treatment in 2015 with a decline ever since… Estimates are that there is more HepC in the US today than ever. That red shaded part is people who didn’t get an available cure. The gap between goal and shot is getting bigger year by year.
Pharma parrots ‘follow the science’ a lot, but it is unclear from this chart which science it follows… It’s not decision science, as this blog covers. It clearly also isn’t sociology, behavioural science, anthropology, economics or other disciplines, all of which are part of this picture.
But I’d be interested to hear from anyone who understands this picture and what it represents: why, when ‘we’ launch a cure do people who need it not get it?